Comments on Weifang's Key Projects-Allgens International Health Science and Technology Industrial Park!

On October 27, Liu Shuguang, Secretary of the Weifang Municipal Party Committee and Director of the Standing Committee of the Municipal People's Congress, led the party and government leaders of Weifang City, as well as the party and government leaders of Weifang City's districts and counties to observe and comment on the key projects under construction in Weifang City.

Allgens International Health Technology Industrial Park under construction site

The leaders of the municipal party committee and municipal government observed and commented on the construction site of Allgens International Health Science and Technology Industrial Park.

Allgens International Health Science and Technology Industrial Park is a key project in Fangzi District, Weifang City. The project is invested and constructed by Beijing Allgens Pharmaceutical Technology Co., Ltd., a national high-tech enterprise, and adopts the "government-industry-university-research fund" joint development model to establish Weifang high-end equity The investment fund helps enterprises to carry out investment and park construction through fund investment.

The project, in conjunction with Professor A. Mikos, Academician of American Academy of Sciences and Medical College, Vice Chairman of South Korea Biomaterials Society, Professor I. S. Lee of Yonsei University, Professor Wang Xiumei of School of Materials Science and Technology of Tsinghua University and other top international biomaterial expert teams, established Weifang Allgens International Research Institute of Regenerative Medical Materials to incubate, research and promote the application of advanced biomaterials technology and build an industry research and production base; research and development of artificial bone repair materials products and technologies are among the international advanced level, the core product "skeletal gold" broke the foreign technology monopoly.

At present, Allgens's products have been put into use in more than 600 tertiary hospitals across the country and have successfully entered the US market. After the completion of the project, it will become the largest R & D and production base of collagen and medical bionic materials in Asia, and the world's leading R & D and production base of "bionic artificial bone" and other high-end medical devices.The two German high-end orthopedic medical device companies that Liu Shuji led to Germany this time will also settle here.